GYRE THERAPEUTICS, INC. (GYRE) — Institutional Holders, Q2 2026

61 institutional investment managers reported a GYRE position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $57.1M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

GYRE in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

12

Added to

30

Trimmed

10

Sold out

7

Biggest buyers

  1. SC CHINA HOLDING LtdNew · +3,750,299 sh+$24.7M
  2. Octagon Capital AdvisorsNew · +954,416 sh+$6.3M
  3. BlackRockAdded · +235,313 sh+$1.6M
  4. GEODE CAPITAL MANAGEMENTAdded · +101,536 sh+$669.1K
  5. VANGUARD PORTFOLIO MANAGEMENTAdded · +54,139 sh+$356.8K

Biggest sellers

  1. VANGUARD CAPITAL MANAGEMENTTrimmed · -107,277 sh-$707.0K
  2. Brevan Howard Capital ManagementSold out · -13,808 sh-$91.0K
  3. SBI Securities , Ltd.Trimmed · -4,087 sh-$26.9K
  4. FMRTrimmed · -3,743 sh-$24.7K
  5. Tower Research Capital (TRC)Trimmed · -3,294 sh-$21.7K

GYRE 13F holders ranked 1–61 of 61

Institutional investors reporting a position in GYRE THERAPEUTICS, INC. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
SC CHINA HOLDING Ltd#1 · 3,750,299 sh$24.7MNew
BlackRock#2 · 993,943 sh$6.6M+31.0%
Octagon Capital Advisors#3 · 954,416 sh$6.3MNew
VANGUARD CAPITAL MANAGEMENT#4 · 876,927 sh$5.8M-10.9%
GEODE CAPITAL MANAGEMENT#5 · 532,950 sh$3.5M+23.5%
STATE STREET#6 · 245,402 sh$1.6M+13.4%
CHARLES SCHWAB INVESTMENT MANAGEMENT#7 · 184,286 sh$1.2M+11.5%
NORTHERN#8 · 169,537 sh$1.1M+26.7%
SBI Securities , Ltd.#9 · 166,750 sh$1.1M-2.4%
VANGUARD FIDUCIARY#10 · 151,073 sh$995.6K+9.7%
VANGUARD PORTFOLIO MANAGEMENT#11 · 123,953 sh$816.9K+77.5%
GOLDMAN SACHS GROUP#12 · 86,235 sh$568.3K+17.9%
Bank of New York Mellon#13 · 62,750 sh$413.5K+45.4%
MORGAN STANLEY#14 · 41,691 sh$274.7K+382.5%
ALLIANCEBERNSTEIN L.P.#15 · 24,590 sh$171.4K+12.6%
STRS OHIO#16 · 25,800 sh$170.0K+22.3%
DIMENSIONAL FUND ADVISORS#17 · 25,268 sh$166.5K0.0%
Nuveen#18 · 24,505 sh$161.5KNew
UBS Group AG#19 · 18,763 sh$123.6K-11.0%
MILLENNIUM MANAGEMENT#20 · 18,488 sh$121.8KNew
DEUTSCHE BANK AG\#21 · 17,939 sh$118.2K+69.0%
RHUMBLINE ADVISERS#22 · 16,865 sh$111.1K+28.6%
WELLS FARGO & COMPANY#23 · 16,297 sh$107.4K+279.9%
PRICE T ROWE ASSOCIATES#24 · 15,031 sh$100.0KNew
FMR#25 · 14,974 sh$98.7K-20.0%
ROYAL BANK OF CANADA#26 · 13,195 sh$87.0K+135.4%
BANK OF AMERICA#27 · 12,525 sh$82.5K+18.9%
Polymer Capital Management (US)#28 · 11,780 sh$77.6KNew
Vanguard Global Advisers#29 · 9,983 sh$65.8K0.0%
Police & Firemen's Retirement System of New Jersey#30 · 9,011 sh$59.4K+329.7%
CITIGROUP#31 · 8,586 sh$56.6K+1265.0%
MIRAE ASSET GLOBAL ETFS Ltd.#32 · 8,446 sh$55.7K+50.4%
JPMORGAN CHASE#33 · 7,831 sh$50.5K+51.1%
State of Alaska, Department of Revenue#34 · 5,219 sh$34.0K0.0%
Russell Investments Group, Ltd.#35 · 3,783 sh$24.9K+236.6%
BNP PARIBAS FINANCIAL MARKETS#36 · 3,486 sh$23.0K+35.6%
BARCLAYS PLC#37 · 3,228 sh$21.3K+40.3%
NEW YORK STATE COMMON RETIREMENT FUND#38 · 2,700 sh$17.8K0.0%
Tower Research Capital (TRC)#39 · 2,469 sh$16.3K-57.2%
Legal & General Group Plc#40 · 2,054 sh$13.5K+64.2%
Ameritas Investment Partners#41 · 683 sh$4.5K0.0%
Activest Wealth Management#42 · 533 sh$3.5K0.0%
SRS Capital Advisors#43 · 246 sh$1.6KNew
Sterling Capital Management#44 · 161 sh$1.1K+172.9%
GAMMA Investing#45 · 146 sh$962.00+78.0%
Physician Wealth Advisors#46 · 82 sh$541.00New
Bare Financial Services#47 · 79 sh$521.00New
GoalVest Advisory#48 · 50 sh$330.000.0%
OSAIC#49 · 44 sh$288.00+15.8%
Allworth Financial#50 · 38 sh$251.00-94.7%
EverSource Wealth Advisors#51 · 20 sh$133.00-87.7%
Caitong International Asset Management , Ltd#52 · 15 sh$99.00+400.0%
Integrated Wealth Concepts#53 · 14 sh$94.00New
Farther Finance Advisors#54 · 8 sh$53.00New
Optiver Holding B.V.#55 · 6 sh$40.00-94.1%
Smartleaf Asset Management#56 · 6 sh$39.000.0%
Essential Partners#57 · 1 sh$7.00-75.0%
ROTHSCHILD INVESTMENT#58 · 1 sh$7.00New
MassMutual Private Wealth & , FSB#59 · 0 sh$0.00-100.0%
Covestor Ltd#60 · 48 sh$0.00+242.9%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#61 · 166 sh—-74.0%

Funds that sold out of GYRE in Q2 2026 (7)

Held GYRE at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held GYRE in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
Brevan Howard Capital Management13,808 sh$96.2K
SIMPLEX TRADING674 sh$4.7K
NISA INVESTMENT ADVISORS102 sh$711.00
US BANCORP \DE\98 sh$683.00
Advisory Services Network66 sh$460.00
MassMutual Private Wealth & , FSB12 sh$84.00
MAI Capital Management4 sh$28.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.